GEIST:UPC Searchengine

UPC_CFI_14/2023

Amgen Inc. v. Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Groupe S.A., Sanofi Winthrop Industrie S.A., Regeneron Pharmaceuticals Inc.

Datum
2024-02-02
Kammer
Munich (DE) Local Division
Verfahrensart
Infringement Action
Sprache
EN

Metadaten

Fall-IDUPC_CFI_14-2023-f047daabc378
Aktenzeichen
RegisterzeichenUPC_CFI_14/2023
EntscheidungsreferenzORD_392/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 7

Local Division Munich UPC_CFI_14/2023 Headnotes: Unanimous requests by all parties directed to a Local or Regional Division to refer a counterclaim for revocation to the Central Division for decision will be granted unless strong counterarguments require a different decision. Keywords: Article 33(3) UPCA; Rule 37 RoP; agreement of parties; discretion to refer counterclaim for revocation to central division; discretion to proceed with infringement proceedings; discretion to stay infringement proceedings. UPC_CFI_14/2023 2 Order in the proceedings before the Court of First Instance of the Unified Patent Court relating to European Patent 3 666 797 delivered on 02/02/2024 Date of receipt of Statement of claim : 01/06/2023 CLAIMANT 1) Amgen Inc. One Amgen Center Drive, Mail-Stop 28-2-C - 91320- ...